
Drotvib M 80mg/250mg Tablet
Marketer
Vybia Healthcare
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Drotvib M 80mg/250mg Tablet
Combiflam M 80mg/250mg tablets are a dual-action formulation indicated for abdominal pain relief. This medication effectively alleviates abdominal pain, distension, discomfort, and spasms by relaxing gastrointestinal muscles and inhibiting pain-inducing neurotransmitters. Combiflam M 80mg/250mg tablets should be administered with food, following your physician's prescribed dosage and regimen. Dosage adjustments depend on individual response and condition severity. Continue treatment as directed; premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your healthcare provider of all concurrent medications, as interactions are possible. Commonly reported side effects include diarrhea, nausea, vomiting, abdominal pain, dry mouth, anorexia, thirst, and heartburn; most are transient. Report any concerning side effects immediately. Dizziness and somnolence may occur; avoid driving or tasks requiring alertness until effects are known. Alcohol consumption should be avoided due to potential dizziness exacerbation. Disclose pregnancy, pregnancy planning, breastfeeding, or kidney/liver impairment to your doctor before commencing treatment to ensure appropriate dosage.
Primary Ingredients of Drotvib M 80mg/250mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Drotvib M 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Drotvib M 80mg/250mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Drotvib M 80mg/250mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.
Common Side effects of Drotvib M 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Drotvib M 80mg/250mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Drotvib M 80mg/250mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.
How Drotvib M 80mg/250mg Tablet works:
Drotvib M, an 80mg/250mg tablet, combines drotaverine and mefenamic acid to alleviate abdominal pain and cramping. Drotaverine, an antispasmodic, targets and reduces abdominal muscle spasms. Mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory substances responsible for abdominal discomfort and swelling.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Drotvib M 80mg/250mg tablets.
PregnancyCONSULT YOUR DOCTOR
The use of Drotvib M 80mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Drotvib M 80mg/250mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Drotvib M 80mg/250mg Tablets, a potential side effect of this medication due to the risk of dizziness.
KidneyCAUTION
Patients with impaired kidney function should use Drotvib M 80mg/250mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Drotvib M 80mg/250mg tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should use Drotvib M 80mg/250mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Drotvib M 80mg/250mg Tablet :
Should you forget to take a Drotvib M 80mg/250mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Drotvib M 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
